Flagship explainer
What drives 10x Genomics, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$43.5M | FY2025 |
| |
| Income before tax | −$39.9M | FY2025 |
|
| Operating income | −$61M | FY2025 |
|
| $643M | FY2025 |
| |
| Ending assets | $1.0B | FY2025 |
|
| Beginning assets | $919M | FY2024 |
|
| $796M | FY2025 |
| |
| $710M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001628280-26-007822
- SEC filingFiling detailsAccession 0001770787-25-000013